Platelet Transfusion Therapy

被引：30

作者：

Thiagarajan, Perumal ^{[1
,2
]}

Afshar-Kharghan, Vahid ^{[3
]}

机构：

[1] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Dept Pathol, Houston, TX 77030 USA

[2] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Dept Med, Houston, TX 77030 USA

[3] MD Anderson Canc Ctr, Sect Benign Hematol, Houston, TX 77030 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 27卷 / 03期

关键词：

Platelet transfusion; Alloimmunization; Transfusion triggers; Pathogen reduction; PATHOGEN INACTIVATION; CROSS-MATCH; APHERESIS PLATELETS; BLEEDING DIATHESIS; IN-VITRO; PHOSPHATIDYLSERINE; INCREMENTS; ALLOIMMUNIZATION; THROMBOCYTOPENIA; PERMEABILITY;

D O I：

10.1016/j.hoc.2013.03.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Platelet transfusion therapy has become an integral part of the treatment of patients with hematological and solid tumor malignancy receiving chemotherapy. Since its introduction almost 60 years ago, several advances and refinements have been introduced in the collection, storage, and administration to improve the safety and efficacy of platelet transfusion. This review summarizes the current practice and clinical approach to patients with thrombocytopenia. Existing evidence-based guidelines for appropriate platelet transfusion is reviewed.

引用

页码：629 / +

页数：16

共 50 条

[31] Platelet Transfusion in Perioperative Medicine
Thiele, Thomas
Greinacher, Andreas
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020, 46 (01) : 50 - 61
[32] Platelet transfusion in adults: An update
Garraud, O.
Hamzeh-Cognasse, H.
Chalayer, E.
Duchez, A. C.
Tardy, B.
Oriol, P.
Haddad, A.
Guyotat, D.
Cognasse, F.
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2023, 30 (01) : 147 - 165
[33] CLINICAL ASPECTS OF PLATELET TRANSFUSION
WILLIAMSON, LM
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (05) : 643 - 646
[34] Platelet transfusion: basic aspects
Holbro, Andreas
Infanti, Laura
Sigle, Joerg
Buser, Andreas
SWISS MEDICAL WEEKLY, 2013, 143
[35] Platelet Transfusion for Patients With Cancer
Fletcher, Craig H.
DomBourian, Melkon G.
Millward, Peter A.
CANCER CONTROL, 2015, 22 (01) : 47 - 51
[36] Platelet transfusion: Current challenges
Humbrecht, C.
Kientz, D.
Gachet, C.
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2018, 25 (03) : 151 - 164
[37] Platelet transfusion refractoriness: how do I diagnose and manage?
Cohn, Claudia S.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 527 - 532
[38] Platelet-derived extracellular vesicles play an important role in platelet transfusion therapy
Cai, Zhi
Feng, Junyan
Dong, Nian
Zhou, Pan
Huang, Yuanshuai
Zhang, Hongwei
PLATELETS, 2023, 34 (01)
[39] Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation
Wong, Melissa
Narra, Ravi
Selim, Motaz
Zimmerman, Michael A.
Kim, Joohyun
Padmanabhan, Anand
Hong, Johnny C.
JOURNAL OF SURGICAL RESEARCH, 2020, 255 : 99 - 105
[40] Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study
Arabi, Saeed
Almahayni, Abdullah O.
Alomair, Abdulrahman A.
Masuadi, Emad M.
Damlaj, Moussab
Al-Dorzi, Hasan M.
CRITICAL CARE RESEARCH AND PRACTICE, 2021, 2021

← 1 2 3 4 5 →